Teva announces exclusive launch of generic Viread® in the U.S.
Teva announced the exclusive launch of generic Viread® (tenofovir disoproxil fumarate) tablets 300 mg in the U.S. Tenofovir disoproxil fumarate tablets are a nucleotide analog HIV-1 reverse transcriptase inhibitor indicated in combination with other antiretroviral agents for the treatment of HIV-1. December 15, 2017